Literature DB >> 25920763

Illicit drug use, early age at first use and risk of premenstrual syndrome: A longitudinal study.

Hong Ju1, Mark Jones2, Gita D Mishra3.   

Abstract

BACKGROUND: Premenstrual syndrome (PMS) is common among women of reproductive age. Limited studies have investigated the long-term association between illicit drug use and PMS.
METHODS: The 1973-1978 cohort from the Australian Longitudinal Study on Women's Health, a prospective cohort study, was followed up for 13-year from 2000 to 2012. Data were collected through self-reported questionnaires on all variables, including PMS, illicit drug use and a range of sociodemographic, lifestyle, reproductive and psychological factors.
RESULTS: When the women were 22-27 years of age, over 40% use illicit drug in the last 12 months, 9% first used drug before age 15 years and approximately 35% reported PMS. Over the study period, the prevalence of drug use in the last 12 months declined whereas that of PMS remained fairly stable except an increase when they were 34-39 years old. Generalised estimating equations analysis showed that, compared to never drug users, significantly higher odds of reporting PMS were detected for illicit drug use in the last 12 months: multiple drugs (odds ratio (OR) 1.31, 95% confidence interval (CI) 1.21, 1.43), exclusive marijuana (OR 1.23, 95% CI 1.08, 1.40). A higher odds of PMS was identified for age at first drug use before 15 years (OR 1.20, 95% CI 1.03, 1.40).
CONCLUSIONS: Illicit drug use in the last 12 months, especially early age at first use and multiple drug use, is associated with increased risk of PMS. However current study is unable to prove causality.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Illicit drugs; Longitudinal studies; PMS; Premenstrual syndrome; Substance use

Mesh:

Year:  2015        PMID: 25920763     DOI: 10.1016/j.drugalcdep.2015.03.037

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  3 in total

1.  Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study.

Authors:  A Slyepchenko; B N Frey; B Lafer; A A Nierenberg; G S Sachs; R S Dias
Journal:  Acta Psychiatr Scand       Date:  2017-08-28       Impact factor: 6.392

2.  Licit Substance Use and Premenstrual Syndrome Symptom Severity in Female College Students.

Authors:  Kathryn Polak; Pamela Nora; Bridget Perry; Caitlin Martin; Pam Dillon; Leroy Thacker; Sarah Nance; Susan Kornstein; Dace Svikis
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-05-02

Review 3.  Premenstrual syndrome and alcohol consumption: a systematic review and meta-analysis.

Authors:  María Del Mar Fernández; Jurgita Saulyte; Hazel M Inskip; Bahi Takkouche
Journal:  BMJ Open       Date:  2018-04-16       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.